Elevated serum free light chains are associated with inferior event free and overall survival in Hodgkin lymphoma-Reference-Cited by-同舟云学术

Elevated serum free light chains are associated with inferior event free and overall survival in Hodgkin lymphoma

Published:2011-10-17 Issue:12 Volume:86 Page:998-1000
ISSN:0361-8609
Container-title:American Journal of Hematology
language:en
Short-container-title:Am. J. Hematol.

Author:

Thompson Carrie A.,Maurer Matthew J.,Cerhan James R.,Katzmann Jerry A.,Ansell Stephen M.,Habermann Thomas M.,Macon William R.,Weiner George J.,Link Brian K.,Witzig Thomas E.

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/ajh.22168/fullpdf

Reference17 articles.

1. Highly sensitive, automated immunoassay for immunoglobulin free light chains in serum and urine;Bradwell;Clin Chem,2001

2. Diagnostic performance of quantitative kappa and lambda free light chain assays in clinical practice;Katzmann;Clin Chem,2005

3. Serum free light chain ratio is an independent risk factor for progression in monoclonal gammopathy of undetermined significance;Rajkumar;Blood,2005

4. Immunoglobulin free light chains and solitary plasmacytoma of bone;Dingli;Blood,2006

5. Quantitative analysis of serum free light chains. A new marker for the diagnostic evaluation of primary systemic amyloidosis;Abraham;Am J Clin Pathol,2003

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unraveling the Immune Microenvironment in Classic Hodgkin Lymphoma: Prognostic and Therapeutic Implications;Biology;2023-06-15

2. Inflammatory microenvironment in classical Hodgkin’s lymphoma with special stress on mast cells;Frontiers in Oncology;2022-10-13

3. Screening Tests for Early Diagnosis of Multiple Myeloma and Related Plasma Cell Disorders;The Korean Journal of Medicine;2021-10-01

4. Immune Microenvironment Features and Dynamics in Hodgkin Lymphoma;Cancers;2021-07-20

5. Serum and Urine Protein Electrophoresis and Serum-Free Light Chain Assays in the Diagnosis and Monitoring of Monoclonal Gammopathies;The Journal of Applied Laboratory Medicine;2020-11-01